Back to Top
Go Back
Journal Photo for Current Research in Drug Discovery
Peer reviewed only Open Access

Current Research in Drug Discovery (CRDD)

Publisher : Science Publications
Drug discovery and development assay development high‑throughput screening
e-ISSN 2333-3243
p-ISSN 2333-3235
Issue Frequency Quarterly
Est. Year 2014
Mobile 971568750657
Language English
APC YES
Email editors@scipub.org

Journal Descriptions

Current Research in Drug Discovery is a peer-reviewed open access journal that publishes original research papers and review articles on drug discovery and development. Focused on small molecules, specific areas of interest include screening technologies, target and lead identification and validation, laboratory automation, high throughput screening, assay development and validation, high content analysis, data mining, biomarkers discovery, ADME, BioMEMS, microfluidics, sample management, biobanking, cell based assay, 3D cell culture, phenotypic screening. We strongly encourage young researchers to submit their original works.The journal focuses on critical topics such as screening technologies, assay development and validation, target and lead identification and validation, high‑content analysis, data mining strategies, biomarkers discovery, and experimental approaches like high‑throughput screening and 3D cell culture systems. Additionally, it covers innovative areas including laboratory automation, microfluidics, sample management, and biobanking, which are key to modern drug discovery workflows. By encouraging the submission of original studies and reviews, Current Research in Drug Discovery accelerates communication of scientific knowledge across academia and industry. The quarterly publication cycle and open‑access model ensure timely dissemination and broad visibility of research findings, supporting global collaboration in the pharmaceutical and biotechnology fields.

Current Research in Drug Discovery (CRDD) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Drug discovery and development, assay development, high‑throughput screening, target and lead identification, biomarkers discovery, ADME, phenotypic screening, microfluidics, laboratory automation technologies, screening technologies, target and lead identification and validation, laboratory automation, high throughput screening, assay development and validation, high content analysis, data mining, BioMEMS, sample management, biobanking, cell based assay, 3D cell culture , Online or Print , Quarterly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2333-3235, E-ISSN: 2333-3243, Established: 2014,
  • Does Not Provide Crossref DOI
  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing